Back to Invesco Ltd. Invesco Ltd.

PRAXPRAX
Showing 8 of 10 quarters

Position history for Invesco Ltd.Invesco Ltd.'s holdings in PRAXIS PRECISION MEDICINES I

Yes. Invesco holds 537,548 shares of PRAX (Praxis Precision Medicines), worth $180M, as of its Q2 2026 13F filing. It increased the position from 61,397 shares in Q1 2026. Invesco has held PRAX since Q1 2024, across 10 quarterly 13F filings.

Current Value

$180M

Current Shares

537,548

Total Value Change

+$173.8M

Total Shares Change

+429,835

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
537,548
+775.5%
$180M0.0%$334.79
49
2026-Q1
Decreased
61,397
-20.4%
$19.8M0.0%$318.22
0
2025-Q4
Increased
77,088
+269.4%
$22.7M0.0%$297.02
46
2025-Q3
Increased
20,868
+30.9%
$1.1M0.0%$52.38
32
2025-Q2
Increased
15,939
+36.5%
$670,2350.0%$43.00
32
2025-Q1
Decreased
11,678
-86.6%
$442,2460.0%$38.66
0
2024-Q4
Decreased
86,983
-19.3%
$6.7M0.0%$76.26
0
2024-Q3
Increased
107,713
+1122.3%
$6.2M0.0%$57.83
44

Other major holders of PRAX: Jupiter Topco LLC, Janus Henderson Group Ltd., Orbis Allan Gray Ltd, FMR LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used